News Archives | Sagittal Pharma Consulting

Reach out to us

Home
Services
Our Services
Clinical Development Safety
Our expertise ensures your safety processes are efficient, compliant, and aligned with regulatory expectations.

Risk Management
From risk assessment to ongoing monitoring, we provide strategic solutions tailored to your product’s unique safety profile.

Safety Operations and PV System Build
Our expertise ensures your safety processes are efficient, compliant, and aligned with regulatory expectations.

GCP and PV Inspection Readiness/Audit
By preparing your team and processes for inspections, we support accurate recording, processing, and maintenance of critical information.
QPPV and LPPV Services
Our expert services help you establish and manage both QPPV oversight and LPPV networks, ensuring compliance with global and regional PV requirements.

PV Requirements for Product Launch
We provide end-to-end PV support to establish a fully functional system that meets global and regional regulatory requirements.

Post Marketing Pharmacovigilance
We support your ongoing safety surveillance, risk management, and regulatory reporting, helping maintain product integrity and compliance.
Resources
Contact
About

News

Essjay & Sagittal 2026 Offsite: Regulatory Updates

By Michelle Parkes|2026-04-24T08:57:04+01:0024 April 2026|Categories: News|

Essjay & Sagittal 2026 Offsite: AI Update

By Michelle Parkes|2026-04-24T08:55:16+01:0024 April 2026|Categories: News|

Essjay & Sagittal 2026 Offsite: ICH GCP E6 (R3): Risk Expectations vs Reality

By Michelle Parkes|2026-04-24T08:52:40+01:0024 April 2026|Categories: News|

Essjay & Sagittal 2026 Offsite: CIOMS Benefit Risk Framework

By Michelle Parkes|2026-04-24T08:50:18+01:0024 April 2026|Categories: News|

AI in PV – What the CIOMS WG XIV Report Means in Practice

By Michelle Parkes|2026-03-04T08:55:57+00:004 March 2026|Categories: News|

Sagittal Pharma Consulting and Essjay Solutions Offsite 2026

By Michelle Parkes|2026-03-03T15:28:47+00:003 March 2026|Categories: News|

Reflections from the DIA QPPV Forum 2025 – Amsterdam

By Michelle Parkes|2025-12-10T13:08:28+00:0010 December 2025|Categories: News|

Making ICH GCP E6(R3) Work in Practice

By Michelle Parkes|2025-12-15T12:05:04+00:009 December 2025|Categories: News|

AI and the Future of Safety: Reflections from World Drug Safety Congress Europe 2025

By Michelle Parkes|2025-11-20T10:28:32+00:0020 November 2025|Categories: News|

Personal Reflections from the World Drug Safety Congress Europe 2025

By Michelle Parkes|2025-11-20T09:11:58+00:0020 November 2025|Categories: News|